Gemtuzumab and septic shock Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #5134221-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Oct 10, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplasia, neutropenia, oliguria, pneumonitis, septic shock, syncope, thrombocytopenia. Gemtuzumab dosage: 9.5 MG. During the same period patient was treated with FUROSEMIDE, MEROPENEM, AMIKACIN, TEICOPLANIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5192195-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Dec 18, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia, pneumonitis, septic shock, thrombocytopenia. Gemtuzumab dosage: 9.5 MG,. During the same period patient was treated with FUROSEMIDE, MEROPENEM, AMIKACIN, TEICOPLANIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5026230-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from PORTUGAL on May 29, 2006. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cardiac arrest , pseudomonal sepsis, septic shock. Gemtuzumab dosage: CONSOLIDATION: TOTAL CUMULATIVE DOSE TOTAL 5MG INTRAVENOUS; SEE IMAGE. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, IDARUBICIN, NOVANTRONE, ETOPOSIDE, IMIPENEM. Patient died.

Gemtuzumab Side Effects Report #5034741-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from PORTUGAL on June 14, 2006. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cardiac arrest , pseudomonal sepsis, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, IDARUBICIN, NOVANTRONE, ETOPOSIDE, IMIPENEM. Patient died.


Gemtuzumab Side Effects Report #4869663-0
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Dec 20, 2005. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: septic shock. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4875723-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: septic shock. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4972941-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on Mar 29, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, septic shock. Gemtuzumab dosage: 12 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRON. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5043603-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on June 16, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, septic shock. Gemtuzumab dosage: 12 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4906949-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Jan 26, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anuria, atelectasis, hypotension, intestinal ischaemia, pleural effusion, septic shock. Gemtuzumab dosage: 9 MG 1X PER 1 DAY. During the same period patient was treated with MEROPENEM, AMIKACIN, TEICOPLANIN. Patient died.


Gemtuzumab Side Effects Report #4928868-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Feb 15, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: abdominal pain , anuria, atelectasis, hypotension, intestinal ischaemia, neutropenia, pleural effusion, septic shock. Gemtuzumab dosage: 9 MG 1X PER 1 DAY. During the same period patient was treated with MEROPENEM, AMIKACIN, TEICOPLANIN. Patient died.

Gemtuzumab Side Effects Report #5611055-0
Gemtuzumab side effect was reported by a Physician from CANADA on Jan 30, 2008. Female patient, 58 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, septic shock, tumour lysis syndrome. Gemtuzumab dosage: 12 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 01/19/2008.

Gemtuzumab Side Effects Report #5270170-4
Gemtuzumab side effect was reported by a Physician from ITALY on Mar 15, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hypotension, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with AMIKACIN, TEICOPLANIN, MEROPENEM. Patient died on 01/25/2006.

Gemtuzumab Side Effects Report #5380944-7
Gemtuzumab side effect was reported by a Physician from ITALY on July 04, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, multi-organ failure, septic shock. Gemtuzumab dosage: unknown. Patient died on 06/25/2007.

Gemtuzumab Side Effects Report #5383162-1
Gemtuzumab side effect was reported by a Physician from ITALY on July 09, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: septic shock. Gemtuzumab dosage: ACTUAL DOSE GIVEN 10 MG; CUMULATIVE DOSE GIVEN 20 MG. During the same period patient was treated with ETOPOSIDE, PREDNISOLONE, DOPAMINE, MORPHINE, MITOXANTRONE, CYTARABINE. Patient died on 07/01/2007.


Gemtuzumab Side Effects Report #5409292-3
Gemtuzumab side effect was reported by a Physician from ITALY on Aug 03, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia, infection  and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: septic shock. Gemtuzumab dosage: ACTUAL DOSE GIVEN 10 MG; CUMULATIVE DOSE GIVEN 20 MG. During the same period patient was treated with ETOPOSIDE, CYTARABINE, CANCIDAS, TAZOCIN, ZYVOX, LEVOFLOXACIN, AMBISOME, MITOXANTRONE. Patient died on 07/01/2007.

Gemtuzumab Side Effects Report #5445027-6
Gemtuzumab side effect was reported by a Physician from ITALY on Sept 03, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient died on 08/21/2007.

Gemtuzumab Side Effects Report #5535219-X
Gemtuzumab side effect was reported by a Physician from ITALY on Nov 26, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, METHYLPREDNISOLONE, MEROPENEM. Patient died on 08/21/2007.

Gemtuzumab Side Effects Report #5573686-6
Gemtuzumab side effect was reported by a Physician from ITALY on Dec 21, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, septic shock. Gemtuzumab dosage: unknown. Patient died on 06/25/2007.

Gemtuzumab Side Effects Report #5591881-7
Gemtuzumab side effect was reported by a Physician from ITALY on Jan 04, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, multi-organ failure, septic shock, staphylococcal infection . Gemtuzumab dosage: unknown. Patient died on 06/24/2007.


Gemtuzumab Side Effects Report #5055220-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on July 05, 2006. Female patient, 70 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, arrhythmia , blood lactate dehydrogenase increased, electrocardiogram st segment depression, septic shock, ventricular tachycardia. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, RAMIPRIL. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5055222-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on July 05, 2006. Male patient, 70 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, arrhythmia , blood lactate dehydrogenase increased, electrocardiogram st segment depression, septic shock, ventricular tachycardia. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, RAMIPRIL. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5056321-5
Gemtuzumab side effect was reported by a Health Professional from GERMANY on July 05, 2006. Male patient, 70 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: myocardial infarction, septic shock, ventricular tachycardia. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5028051-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on June 02, 2006. Male patient, 70 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: myocardial infarction, septic shock, ventricular tachycardia. Gemtuzumab dosage: 12.18 MG. During the same period patient was treated with RAMIPRIL. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5354356-6
Gemtuzumab side effect was reported by a Physician from ITALY on June 01, 2007. Female patient, weighting 202.8 lb, was diagnosed with acute myeloid leukaemia, vomiting and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, circulatory collapse, diarrhoea, pyrexia, septic shock, vomiting. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ONDANSETRON, ACYCLOVIR, SERTRALINE, IDARUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/29/2007.